TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2021

A Phase 2 Study of Capmatinib in Patients With MET-Altered Lung Cancer Previously Treated With a MET Inhibitor.

Ibiayi Dagogo-Jack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.